A Study of the Safety and Effectiveness of Synvisc-One® (Hylan G-F 20) in Patients With Primary Osteoarthritis of the Hip

Clinical trial NCT01618708 · COMPLETED

Trial details

NCT number: NCT01618708
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Osteoarthritis, Hip

Start date: 2012-09-01
Primary completion: 2015-06-01
Enrollment: 357

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.